Meiji Yasuda Asset Management CO Ltd. Biogen Inc. Transaction History
Meiji Yasuda Asset Management CO Ltd.
- $2.42 Billion
- Q2 2024
A detailed history of Meiji Yasuda Asset Management CO Ltd. transactions in Biogen Inc. stock. As of the latest transaction made, Meiji Yasuda Asset Management CO Ltd. holds 2,229 shares of BIIB stock, worth $449,812. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,229
Previous 2,101
6.09%
Holding current value
$449,812
Previous $453,000
13.91%
% of portfolio
0.02%
Previous 0.02%
Shares
26 transactions
Others Institutions Holding BIIB
# of Institutions
1,050Shares Held
128MCall Options Held
1.22MPut Options Held
1.4M-
Vanguard Group Inc Valley Forge, PA16.6MShares$3.35 Billion0.08% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$3.3 Billion2.78% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.93 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.1MShares$1.43 Billion0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.68MShares$1.15 Billion0.83% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $29.1B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...